What recent performance suggests about Hinge Health (HNGE)

Hinge Health (HNGE) has caught investor attention after recent share price gains, with the stock showing positive moves over the past week, month and past 3 months while the business remains focused on musculoskeletal care technology.

The recent rally has been strong, with a 23.3% 7 day share price return and 76.5% 90 day share price return, which points to momentum building on top of earlier gains.

If strong recent moves in healthcare technology stocks have caught your interest, it could be worth scanning for other AI driven healthcare opportunities using our 35 healthcare AI stocks

With Hinge Health posting recent share price gains, a value score of 2 and a market cap around US$4.3b, the key question now is whether the current price still leaves room for upside or if expectations for future growth are already fully reflected.

Most Popular Narrative: 14.4% Undervalued

The most followed narrative puts Hinge Health's fair value at $64.29 per share, compared with a last close of $55.00. This frames the recent surge against a higher long term target built on detailed growth and margin assumptions.

Rapid adoption of AI across care delivery and internal operations, including Robin and engineering productivity tools, is increasing clinician throughput and product velocity. This trend may structurally improve operating leverage and net margins over time.

Curious what has to happen for that higher value to make sense? The narrative leans on faster revenue expansion, rising margins and a rich future earnings multiple.

Result: Fair Value of $64.29 (UNDERVALUED)

However, this hinges on employers and health plans continuing to pay for digital MSK programs, and on AI tools avoiding regulatory or data privacy setbacks that could hit growth and margins.

Another View: Multiples Paint a Tougher Picture

While the narrative and our cash flow based work point to Hinge Health trading below fair value, the current P/S of 6.6x looks demanding next to the US Healthcare average of 1.2x, the peer average of 4x and even the 6.2x fair ratio that the market could move towards. That gap suggests meaningful valuation risk if sentiment cools.

For a closer look at how this pricing stacks up against fundamentals, see our See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment leaning positive but risks still on the table, it makes sense to look through the details yourself and decide quickly where you stand. To see what is driving optimism around the stock, take a closer look at its 3 key rewards

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that could suit your goals, so keep scanning and keep your watchlist evolving.

• Target potential mispricings by checking out 51 high quality undervalued stocks that pair solid fundamentals with attractive valuations.
• Strengthen your income stream by reviewing 12 dividend fortresses offering higher yields with a focus on resilience.
• Prioritise stability by searching through 72 resilient stocks with low risk scores that score well on financial robustness and consistency.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.